|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Recommended reads: stem cells for ALS treatment trial, epigenome editing, astronaut mutations, '3-person embryo' DNA
|
|
|
|
A new stem cells for ALS treatment trial represents a big step forward. It's early days still but this trial shows feasibility and provides a helpful foundation for moving forward. It also highlights challenges. The work is from a team led by Clive Svendsen. Stem cells for ALS treatment trial Here's the study. Transplantation of human neural progenitor cells secreting …
|
|
|
|
|
|
|
|
Tributes to NYSCF leader & stem cell advocate Susan Solomon
|
|
|
|
It was a shock to learn today that New York Stem Cell Foundation CEO and Co-Founder Susan Solomon had passed away yesterday after a long battle with ovarian cancer. I met Susan a few times over the years and was always struck by her positive energy. At a practical level she got big things done and enabled others to do …
|
|
|
|
|
|
|
|
Paper sparks renewed interest in transdifferentiation & clinical potential
|
|
|
|
There was a time when I thought transdifferentiation based approaches might quickly move into clinical trials. Then things kind of cooled off. We didn't see many papers reporting methods to transdifferentiate cells. I still think that this technology, sometimes called direct reprogramming, has major potential. A new paper on making human brain cells this way got me thinking more about transdifferentiation …
|
|
|
|
|
|
|
|
Review of cord banker Viacord: dubious autism claims & other concerns
|
|
|
|
Viacord is one of the most well known firms in the for-profit cord blood banking industry. Today's post is a review of the firm. I see concrete reasons for concern. What is Viacord? | Dubious autism claims | Viacord cost | Overall Review | References What is Viacord? As a cord blood banking firm, Viacord freezes cord materials for new parents. …
|
|
|
|
|
|
